1,062
Views
1
CrossRef citations to date
0
Altmetric
ISV Annual Congress SF – Short Report

A novel SARS-CoV-2 subunit vaccine engineered on an immune-activating platform technology

, & ORCID Icon
Article: 2062971 | Received 20 Jan 2022, Accepted 31 Mar 2022, Published online: 08 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.